These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 133806)

  • 21. Immunostaining reveals accumulation of serotonin and coexistence with tyrosine hydroxylase in hypothalamic neurons of acutely stalk-sectioned baboons.
    Thind KK; Boggan JE; Song T; Goldsmith PC
    Neuroendocrinology; 1987 Feb; 45(2):130-45. PubMed ID: 2883596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.
    Pu C; Fisher JE; Cappon GD; Vorhees CV
    Brain Res; 1994 Jun; 649(1-2):217-24. PubMed ID: 7953636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons.
    Hervé D; Pickel VM; Joh TH; Beaudet A
    Brain Res; 1987 Dec; 435(1-2):71-83. PubMed ID: 2892580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
    Sanchez V; Camarero J; Esteban B; Peter MJ; Green AR; Colado MI
    Br J Pharmacol; 2001 Sep; 134(1):46-57. PubMed ID: 11522596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats.
    Ryan LJ; Linder JC; Martone ME; Groves PM
    Brain Res; 1990 Jun; 518(1-2):67-77. PubMed ID: 1975218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglial response to degeneration of serotonergic axon terminals.
    Wilson MA; Molliver ME
    Glia; 1994 May; 11(1):18-34. PubMed ID: 8070892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons.
    Van Bockstaele EJ; Cestari DM; Pickel VM
    Brain Res; 1994 Jun; 647(2):307-22. PubMed ID: 7522922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemically induced degeneration of indoleamine-containing nerve terminals in rat brain.
    Baumgarten HG; Lachenmayer L
    Brain Res; 1972 Mar; 38(1):228-32. PubMed ID: 5016002
    [No Abstract]   [Full Text] [Related]  

  • 29. Ipsilateral alterations in tryptophan hydroxylase activity in rat brain after hypothalamic 5,7-di-hydroxytryptamine lesion.
    Ljubić-Thibal V; Diksic M; Hamel E; Raison S; Pujol JF; Weissmann D
    Brain Res; 1996 Jun; 724(2):222-31. PubMed ID: 8828572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Septal efferent axon terminals identified by anterograde degeneration show multiple sites for modulation of neuropeptide Y-containing neurons in the rat dentate gyrus.
    Milner TA; Veznedaroglu E
    Synapse; 1993 Jun; 14(2):101-12. PubMed ID: 8332943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro uptake of dopamine in serotoninergic nerve terminals: a fluorescence histochemical study on vibratome sections of the rat cerebral cortex.
    Berger B
    Adv Biochem Psychopharmacol; 1978; 19():405-8. PubMed ID: 358786
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental degeneration of motor and sensory cortical terminals in the cuneate nucleus of the monkey (Macaca fascicularis).
    Wen CY; Wong WC; Tan CK
    J Anat; 1980 Jan; 130(Pt 1):13-23. PubMed ID: 6767675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphetamine neurotoxicity on dopamine nerve terminals in the caudate nucleus of mice.
    Nwanze E; Jonsson G
    Neurosci Lett; 1981 Oct; 26(2):163-8. PubMed ID: 7301203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomic evidence for a neurotoxic effect of (+/-)-fenfluramine upon serotonergic projections in the rat.
    Molliver DC; Molliver ME
    Brain Res; 1990 Mar; 511(1):165-8. PubMed ID: 2331614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain.
    Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Zanoni R
    Brain Res; 1984 Nov; 318(2):171-80. PubMed ID: 6093923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence.
    Zhou FC; Tao-Cheng JH; Segu L; Patel T; Wang Y
    Brain Res; 1998 Sep; 805(1-2):241-54. PubMed ID: 9733975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raphe origin of serotonergic nerves terminating in the cerebral ventricles.
    Aghajanian GK; Gallager DW
    Brain Res; 1975 May; 88(2):221-31. PubMed ID: 167906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methylation dissociates methamphetamine's neurotoxic and behavioral pharmacologic effects.
    Fasciano J; Hatzidimitriou G; Yuan J; Katz JL; Ricaurte GA
    Brain Res; 1997 Oct; 771(1):115-20. PubMed ID: 9383014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degeneration of noradrenergic nerve terminals in submucous ganglia of the rat duodenum following treatment with 6-hydroxydopamine.
    Wong WC; Helme RD; Smith GC
    Experientia; 1974 Mar; 30(3):282-4. PubMed ID: 4824608
    [No Abstract]   [Full Text] [Related]  

  • 40. Anatomical distribution of serotonin-containing neurons and axons in the central nervous system of the cat.
    Leger L; Charnay Y; Hof PR; Bouras C; Cespuglio R
    J Comp Neurol; 2001 Apr; 433(2):157-82. PubMed ID: 11283957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.